Global Postoperative Nausea and Vomiting Management Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Postoperative Nausea and Vomiting Management market size was valued at USD 1070.1 million in 2022 and is forecast to a readjusted size of USD 2336.2 million by 2029 with a CAGR of 11.8% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Postoperative nausea and vomiting (PONV) management refers to the various strategies and interventions used to prevent or treat nausea and vomiting in patients after surgery.
This report is a detailed and comprehensive analysis for global Postoperative Nausea and Vomiting Management market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Postoperative Nausea and Vomiting Management market size and forecasts, in consumption value ($ Million), 2018-2029
Global Postoperative Nausea and Vomiting Management market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Postoperative Nausea and Vomiting Management market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Postoperative Nausea and Vomiting Management market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Postoperative Nausea and Vomiting Management
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Postoperative Nausea and Vomiting Management market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Acacia Pharma, Roche, Novartis AG, Ani Pharmaceuticals, Inc and Camurus AB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Postoperative Nausea and Vomiting Management market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Postoperative Nausea and Vomiting Management product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Postoperative Nausea and Vomiting Management, with revenue, gross margin and global market share of Postoperative Nausea and Vomiting Management from 2018 to 2023.
Chapter 3, the Postoperative Nausea and Vomiting Management competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Postoperative Nausea and Vomiting Management market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Postoperative Nausea and Vomiting Management.
Chapter 13, to describe Postoperative Nausea and Vomiting Management research findings and conclusion.
Postoperative nausea and vomiting (PONV) management refers to the various strategies and interventions used to prevent or treat nausea and vomiting in patients after surgery.
This report is a detailed and comprehensive analysis for global Postoperative Nausea and Vomiting Management market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Postoperative Nausea and Vomiting Management market size and forecasts, in consumption value ($ Million), 2018-2029
Global Postoperative Nausea and Vomiting Management market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Postoperative Nausea and Vomiting Management market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Postoperative Nausea and Vomiting Management market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Postoperative Nausea and Vomiting Management
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Postoperative Nausea and Vomiting Management market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Acacia Pharma, Roche, Novartis AG, Ani Pharmaceuticals, Inc and Camurus AB, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Postoperative Nausea and Vomiting Management market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Serotonin Antagonists
- Steroids
- Dopamine Antagonists
- Neurokinin NK-1 Receptor Antagonists
- Non-pharmacological Treatment
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies and Drug Stores
- Acacia Pharma
- Roche
- Novartis AG
- Ani Pharmaceuticals, Inc
- Camurus AB
- Sanofi S.A.
- Helsinn Holding S.A.
- Eisai Corporation
- Merck and Co.
- GlaxoSmithKline Corporation
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Postoperative Nausea and Vomiting Management product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Postoperative Nausea and Vomiting Management, with revenue, gross margin and global market share of Postoperative Nausea and Vomiting Management from 2018 to 2023.
Chapter 3, the Postoperative Nausea and Vomiting Management competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Postoperative Nausea and Vomiting Management market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Postoperative Nausea and Vomiting Management.
Chapter 13, to describe Postoperative Nausea and Vomiting Management research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Postoperative Nausea and Vomiting Management
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Postoperative Nausea and Vomiting Management by Type
1.3.1 Overview: Global Postoperative Nausea and Vomiting Management Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type in 2022
1.3.3 Serotonin Antagonists
1.3.4 Steroids
1.3.5 Dopamine Antagonists
1.3.6 Neurokinin NK-1 Receptor Antagonists
1.3.7 Non-pharmacological Treatment
1.4 Global Postoperative Nausea and Vomiting Management Market by Application
1.4.1 Overview: Global Postoperative Nausea and Vomiting Management Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Online Pharmacies
1.4.4 Retail Pharmacies and Drug Stores
1.5 Global Postoperative Nausea and Vomiting Management Market Size & Forecast
1.6 Global Postoperative Nausea and Vomiting Management Market Size and Forecast by Region
1.6.1 Global Postoperative Nausea and Vomiting Management Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Postoperative Nausea and Vomiting Management Market Size by Region, (2018-2029)
1.6.3 North America Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.4 Europe Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.6 South America Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Acacia Pharma
2.1.1 Acacia Pharma Details
2.1.2 Acacia Pharma Major Business
2.1.3 Acacia Pharma Postoperative Nausea and Vomiting Management Product and Solutions
2.1.4 Acacia Pharma Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Acacia Pharma Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Postoperative Nausea and Vomiting Management Product and Solutions
2.2.4 Roche Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments and Future Plans
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Postoperative Nausea and Vomiting Management Product and Solutions
2.3.4 Novartis AG Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis AG Recent Developments and Future Plans
2.4 Ani Pharmaceuticals, Inc
2.4.1 Ani Pharmaceuticals, Inc Details
2.4.2 Ani Pharmaceuticals, Inc Major Business
2.4.3 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Product and Solutions
2.4.4 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ani Pharmaceuticals, Inc Recent Developments and Future Plans
2.5 Camurus AB
2.5.1 Camurus AB Details
2.5.2 Camurus AB Major Business
2.5.3 Camurus AB Postoperative Nausea and Vomiting Management Product and Solutions
2.5.4 Camurus AB Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Camurus AB Recent Developments and Future Plans
2.6 Sanofi S.A.
2.6.1 Sanofi S.A. Details
2.6.2 Sanofi S.A. Major Business
2.6.3 Sanofi S.A. Postoperative Nausea and Vomiting Management Product and Solutions
2.6.4 Sanofi S.A. Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi S.A. Recent Developments and Future Plans
2.7 Helsinn Holding S.A.
2.7.1 Helsinn Holding S.A. Details
2.7.2 Helsinn Holding S.A. Major Business
2.7.3 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Product and Solutions
2.7.4 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Helsinn Holding S.A. Recent Developments and Future Plans
2.8 Eisai Corporation
2.8.1 Eisai Corporation Details
2.8.2 Eisai Corporation Major Business
2.8.3 Eisai Corporation Postoperative Nausea and Vomiting Management Product and Solutions
2.8.4 Eisai Corporation Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eisai Corporation Recent Developments and Future Plans
2.9 Merck and Co.
2.9.1 Merck and Co. Details
2.9.2 Merck and Co. Major Business
2.9.3 Merck and Co. Postoperative Nausea and Vomiting Management Product and Solutions
2.9.4 Merck and Co. Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck and Co. Recent Developments and Future Plans
2.10 GlaxoSmithKline Corporation
2.10.1 GlaxoSmithKline Corporation Details
2.10.2 GlaxoSmithKline Corporation Major Business
2.10.3 GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Product and Solutions
2.10.4 GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GlaxoSmithKline Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Postoperative Nausea and Vomiting Management Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Postoperative Nausea and Vomiting Management by Company Revenue
3.2.2 Top 3 Postoperative Nausea and Vomiting Management Players Market Share in 2022
3.2.3 Top 6 Postoperative Nausea and Vomiting Management Players Market Share in 2022
3.3 Postoperative Nausea and Vomiting Management Market: Overall Company Footprint Analysis
3.3.1 Postoperative Nausea and Vomiting Management Market: Region Footprint
3.3.2 Postoperative Nausea and Vomiting Management Market: Company Product Type Footprint
3.3.3 Postoperative Nausea and Vomiting Management Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Postoperative Nausea and Vomiting Management Consumption Value and Market Share by Type (2018-2023)
4.2 Global Postoperative Nausea and Vomiting Management Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2023)
5.2 Global Postoperative Nausea and Vomiting Management Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
6.2 North America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
6.3 North America Postoperative Nausea and Vomiting Management Market Size by Country
6.3.1 North America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
6.3.2 United States Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
6.3.3 Canada Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
6.3.4 Mexico Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
7.2 Europe Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
7.3 Europe Postoperative Nausea and Vomiting Management Market Size by Country
7.3.1 Europe Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
7.3.2 Germany Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.3 France Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.5 Russia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.6 Italy Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region
8.3.1 Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Region (2018-2029)
8.3.2 China Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.3 Japan Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.4 South Korea Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.5 India Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.7 Australia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
9.2 South America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
9.3 South America Postoperative Nausea and Vomiting Management Market Size by Country
9.3.1 South America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
9.3.2 Brazil Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
9.3.3 Argentina Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country
10.3.1 Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
10.3.2 Turkey Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
10.3.4 UAE Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Postoperative Nausea and Vomiting Management Market Drivers
11.2 Postoperative Nausea and Vomiting Management Market Restraints
11.3 Postoperative Nausea and Vomiting Management Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Postoperative Nausea and Vomiting Management Industry Chain
12.2 Postoperative Nausea and Vomiting Management Upstream Analysis
12.3 Postoperative Nausea and Vomiting Management Midstream Analysis
12.4 Postoperative Nausea and Vomiting Management Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Postoperative Nausea and Vomiting Management
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Postoperative Nausea and Vomiting Management by Type
1.3.1 Overview: Global Postoperative Nausea and Vomiting Management Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type in 2022
1.3.3 Serotonin Antagonists
1.3.4 Steroids
1.3.5 Dopamine Antagonists
1.3.6 Neurokinin NK-1 Receptor Antagonists
1.3.7 Non-pharmacological Treatment
1.4 Global Postoperative Nausea and Vomiting Management Market by Application
1.4.1 Overview: Global Postoperative Nausea and Vomiting Management Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital Pharmacies
1.4.3 Online Pharmacies
1.4.4 Retail Pharmacies and Drug Stores
1.5 Global Postoperative Nausea and Vomiting Management Market Size & Forecast
1.6 Global Postoperative Nausea and Vomiting Management Market Size and Forecast by Region
1.6.1 Global Postoperative Nausea and Vomiting Management Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Postoperative Nausea and Vomiting Management Market Size by Region, (2018-2029)
1.6.3 North America Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.4 Europe Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.6 South America Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Postoperative Nausea and Vomiting Management Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Acacia Pharma
2.1.1 Acacia Pharma Details
2.1.2 Acacia Pharma Major Business
2.1.3 Acacia Pharma Postoperative Nausea and Vomiting Management Product and Solutions
2.1.4 Acacia Pharma Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Acacia Pharma Recent Developments and Future Plans
2.2 Roche
2.2.1 Roche Details
2.2.2 Roche Major Business
2.2.3 Roche Postoperative Nausea and Vomiting Management Product and Solutions
2.2.4 Roche Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Roche Recent Developments and Future Plans
2.3 Novartis AG
2.3.1 Novartis AG Details
2.3.2 Novartis AG Major Business
2.3.3 Novartis AG Postoperative Nausea and Vomiting Management Product and Solutions
2.3.4 Novartis AG Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Novartis AG Recent Developments and Future Plans
2.4 Ani Pharmaceuticals, Inc
2.4.1 Ani Pharmaceuticals, Inc Details
2.4.2 Ani Pharmaceuticals, Inc Major Business
2.4.3 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Product and Solutions
2.4.4 Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ani Pharmaceuticals, Inc Recent Developments and Future Plans
2.5 Camurus AB
2.5.1 Camurus AB Details
2.5.2 Camurus AB Major Business
2.5.3 Camurus AB Postoperative Nausea and Vomiting Management Product and Solutions
2.5.4 Camurus AB Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Camurus AB Recent Developments and Future Plans
2.6 Sanofi S.A.
2.6.1 Sanofi S.A. Details
2.6.2 Sanofi S.A. Major Business
2.6.3 Sanofi S.A. Postoperative Nausea and Vomiting Management Product and Solutions
2.6.4 Sanofi S.A. Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Sanofi S.A. Recent Developments and Future Plans
2.7 Helsinn Holding S.A.
2.7.1 Helsinn Holding S.A. Details
2.7.2 Helsinn Holding S.A. Major Business
2.7.3 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Product and Solutions
2.7.4 Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Helsinn Holding S.A. Recent Developments and Future Plans
2.8 Eisai Corporation
2.8.1 Eisai Corporation Details
2.8.2 Eisai Corporation Major Business
2.8.3 Eisai Corporation Postoperative Nausea and Vomiting Management Product and Solutions
2.8.4 Eisai Corporation Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Eisai Corporation Recent Developments and Future Plans
2.9 Merck and Co.
2.9.1 Merck and Co. Details
2.9.2 Merck and Co. Major Business
2.9.3 Merck and Co. Postoperative Nausea and Vomiting Management Product and Solutions
2.9.4 Merck and Co. Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 Merck and Co. Recent Developments and Future Plans
2.10 GlaxoSmithKline Corporation
2.10.1 GlaxoSmithKline Corporation Details
2.10.2 GlaxoSmithKline Corporation Major Business
2.10.3 GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Product and Solutions
2.10.4 GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 GlaxoSmithKline Corporation Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Postoperative Nausea and Vomiting Management Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Postoperative Nausea and Vomiting Management by Company Revenue
3.2.2 Top 3 Postoperative Nausea and Vomiting Management Players Market Share in 2022
3.2.3 Top 6 Postoperative Nausea and Vomiting Management Players Market Share in 2022
3.3 Postoperative Nausea and Vomiting Management Market: Overall Company Footprint Analysis
3.3.1 Postoperative Nausea and Vomiting Management Market: Region Footprint
3.3.2 Postoperative Nausea and Vomiting Management Market: Company Product Type Footprint
3.3.3 Postoperative Nausea and Vomiting Management Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Postoperative Nausea and Vomiting Management Consumption Value and Market Share by Type (2018-2023)
4.2 Global Postoperative Nausea and Vomiting Management Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2023)
5.2 Global Postoperative Nausea and Vomiting Management Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
6.2 North America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
6.3 North America Postoperative Nausea and Vomiting Management Market Size by Country
6.3.1 North America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
6.3.2 United States Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
6.3.3 Canada Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
6.3.4 Mexico Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
7.2 Europe Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
7.3 Europe Postoperative Nausea and Vomiting Management Market Size by Country
7.3.1 Europe Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
7.3.2 Germany Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.3 France Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.5 Russia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
7.3.6 Italy Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Postoperative Nausea and Vomiting Management Market Size by Region
8.3.1 Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Region (2018-2029)
8.3.2 China Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.3 Japan Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.4 South Korea Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.5 India Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
8.3.7 Australia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
9.2 South America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
9.3 South America Postoperative Nausea and Vomiting Management Market Size by Country
9.3.1 South America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
9.3.2 Brazil Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
9.3.3 Argentina Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Postoperative Nausea and Vomiting Management Market Size by Country
10.3.1 Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2029)
10.3.2 Turkey Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
10.3.4 UAE Postoperative Nausea and Vomiting Management Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Postoperative Nausea and Vomiting Management Market Drivers
11.2 Postoperative Nausea and Vomiting Management Market Restraints
11.3 Postoperative Nausea and Vomiting Management Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Postoperative Nausea and Vomiting Management Industry Chain
12.2 Postoperative Nausea and Vomiting Management Upstream Analysis
12.3 Postoperative Nausea and Vomiting Management Midstream Analysis
12.4 Postoperative Nausea and Vomiting Management Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Postoperative Nausea and Vomiting Management Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Postoperative Nausea and Vomiting Management Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Postoperative Nausea and Vomiting Management Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Postoperative Nausea and Vomiting Management Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Acacia Pharma Company Information, Head Office, and Major Competitors
Table 6. Acacia Pharma Major Business
Table 7. Acacia Pharma Postoperative Nausea and Vomiting Management Product and Solutions
Table 8. Acacia Pharma Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Acacia Pharma Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Postoperative Nausea and Vomiting Management Product and Solutions
Table 13. Roche Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Roche Recent Developments and Future Plans
Table 15. Novartis AG Company Information, Head Office, and Major Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Postoperative Nausea and Vomiting Management Product and Solutions
Table 18. Novartis AG Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis AG Recent Developments and Future Plans
Table 20. Ani Pharmaceuticals, Inc Company Information, Head Office, and Major Competitors
Table 21. Ani Pharmaceuticals, Inc Major Business
Table 22. Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Product and Solutions
Table 23. Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Ani Pharmaceuticals, Inc Recent Developments and Future Plans
Table 25. Camurus AB Company Information, Head Office, and Major Competitors
Table 26. Camurus AB Major Business
Table 27. Camurus AB Postoperative Nausea and Vomiting Management Product and Solutions
Table 28. Camurus AB Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Camurus AB Recent Developments and Future Plans
Table 30. Sanofi S.A. Company Information, Head Office, and Major Competitors
Table 31. Sanofi S.A. Major Business
Table 32. Sanofi S.A. Postoperative Nausea and Vomiting Management Product and Solutions
Table 33. Sanofi S.A. Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Sanofi S.A. Recent Developments and Future Plans
Table 35. Helsinn Holding S.A. Company Information, Head Office, and Major Competitors
Table 36. Helsinn Holding S.A. Major Business
Table 37. Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Product and Solutions
Table 38. Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Helsinn Holding S.A. Recent Developments and Future Plans
Table 40. Eisai Corporation Company Information, Head Office, and Major Competitors
Table 41. Eisai Corporation Major Business
Table 42. Eisai Corporation Postoperative Nausea and Vomiting Management Product and Solutions
Table 43. Eisai Corporation Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Eisai Corporation Recent Developments and Future Plans
Table 45. Merck and Co. Company Information, Head Office, and Major Competitors
Table 46. Merck and Co. Major Business
Table 47. Merck and Co. Postoperative Nausea and Vomiting Management Product and Solutions
Table 48. Merck and Co. Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck and Co. Recent Developments and Future Plans
Table 50. GlaxoSmithKline Corporation Company Information, Head Office, and Major Competitors
Table 51. GlaxoSmithKline Corporation Major Business
Table 52. GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Product and Solutions
Table 53. GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. GlaxoSmithKline Corporation Recent Developments and Future Plans
Table 55. Global Postoperative Nausea and Vomiting Management Revenue (USD Million) by Players (2018-2023)
Table 56. Global Postoperative Nausea and Vomiting Management Revenue Share by Players (2018-2023)
Table 57. Breakdown of Postoperative Nausea and Vomiting Management by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Postoperative Nausea and Vomiting Management, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Postoperative Nausea and Vomiting Management Players
Table 60. Postoperative Nausea and Vomiting Management Market: Company Product Type Footprint
Table 61. Postoperative Nausea and Vomiting Management Market: Company Product Application Footprint
Table 62. Postoperative Nausea and Vomiting Management New Market Entrants and Barriers to Market Entry
Table 63. Postoperative Nausea and Vomiting Management Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Postoperative Nausea and Vomiting Management Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Postoperative Nausea and Vomiting Management Consumption Value Share by Type (2018-2023)
Table 66. Global Postoperative Nausea and Vomiting Management Consumption Value Forecast by Type (2024-2029)
Table 67. Global Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023)
Table 68. Global Postoperative Nausea and Vomiting Management Consumption Value Forecast by Application (2024-2029)
Table 69. North America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Postoperative Nausea and Vomiting Management Raw Material
Table 100. Key Suppliers of Postoperative Nausea and Vomiting Management Raw Materials
Table 1. Global Postoperative Nausea and Vomiting Management Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Postoperative Nausea and Vomiting Management Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Postoperative Nausea and Vomiting Management Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Postoperative Nausea and Vomiting Management Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Acacia Pharma Company Information, Head Office, and Major Competitors
Table 6. Acacia Pharma Major Business
Table 7. Acacia Pharma Postoperative Nausea and Vomiting Management Product and Solutions
Table 8. Acacia Pharma Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Acacia Pharma Recent Developments and Future Plans
Table 10. Roche Company Information, Head Office, and Major Competitors
Table 11. Roche Major Business
Table 12. Roche Postoperative Nausea and Vomiting Management Product and Solutions
Table 13. Roche Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Roche Recent Developments and Future Plans
Table 15. Novartis AG Company Information, Head Office, and Major Competitors
Table 16. Novartis AG Major Business
Table 17. Novartis AG Postoperative Nausea and Vomiting Management Product and Solutions
Table 18. Novartis AG Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Novartis AG Recent Developments and Future Plans
Table 20. Ani Pharmaceuticals, Inc Company Information, Head Office, and Major Competitors
Table 21. Ani Pharmaceuticals, Inc Major Business
Table 22. Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Product and Solutions
Table 23. Ani Pharmaceuticals, Inc Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Ani Pharmaceuticals, Inc Recent Developments and Future Plans
Table 25. Camurus AB Company Information, Head Office, and Major Competitors
Table 26. Camurus AB Major Business
Table 27. Camurus AB Postoperative Nausea and Vomiting Management Product and Solutions
Table 28. Camurus AB Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Camurus AB Recent Developments and Future Plans
Table 30. Sanofi S.A. Company Information, Head Office, and Major Competitors
Table 31. Sanofi S.A. Major Business
Table 32. Sanofi S.A. Postoperative Nausea and Vomiting Management Product and Solutions
Table 33. Sanofi S.A. Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Sanofi S.A. Recent Developments and Future Plans
Table 35. Helsinn Holding S.A. Company Information, Head Office, and Major Competitors
Table 36. Helsinn Holding S.A. Major Business
Table 37. Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Product and Solutions
Table 38. Helsinn Holding S.A. Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Helsinn Holding S.A. Recent Developments and Future Plans
Table 40. Eisai Corporation Company Information, Head Office, and Major Competitors
Table 41. Eisai Corporation Major Business
Table 42. Eisai Corporation Postoperative Nausea and Vomiting Management Product and Solutions
Table 43. Eisai Corporation Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Eisai Corporation Recent Developments and Future Plans
Table 45. Merck and Co. Company Information, Head Office, and Major Competitors
Table 46. Merck and Co. Major Business
Table 47. Merck and Co. Postoperative Nausea and Vomiting Management Product and Solutions
Table 48. Merck and Co. Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 49. Merck and Co. Recent Developments and Future Plans
Table 50. GlaxoSmithKline Corporation Company Information, Head Office, and Major Competitors
Table 51. GlaxoSmithKline Corporation Major Business
Table 52. GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Product and Solutions
Table 53. GlaxoSmithKline Corporation Postoperative Nausea and Vomiting Management Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 54. GlaxoSmithKline Corporation Recent Developments and Future Plans
Table 55. Global Postoperative Nausea and Vomiting Management Revenue (USD Million) by Players (2018-2023)
Table 56. Global Postoperative Nausea and Vomiting Management Revenue Share by Players (2018-2023)
Table 57. Breakdown of Postoperative Nausea and Vomiting Management by Company Type (Tier 1, Tier 2, and Tier 3)
Table 58. Market Position of Players in Postoperative Nausea and Vomiting Management, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 59. Head Office of Key Postoperative Nausea and Vomiting Management Players
Table 60. Postoperative Nausea and Vomiting Management Market: Company Product Type Footprint
Table 61. Postoperative Nausea and Vomiting Management Market: Company Product Application Footprint
Table 62. Postoperative Nausea and Vomiting Management New Market Entrants and Barriers to Market Entry
Table 63. Postoperative Nausea and Vomiting Management Mergers, Acquisition, Agreements, and Collaborations
Table 64. Global Postoperative Nausea and Vomiting Management Consumption Value (USD Million) by Type (2018-2023)
Table 65. Global Postoperative Nausea and Vomiting Management Consumption Value Share by Type (2018-2023)
Table 66. Global Postoperative Nausea and Vomiting Management Consumption Value Forecast by Type (2024-2029)
Table 67. Global Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023)
Table 68. Global Postoperative Nausea and Vomiting Management Consumption Value Forecast by Application (2024-2029)
Table 69. North America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 70. North America Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 71. North America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 72. North America Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 73. North America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 74. North America Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 75. Europe Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 76. Europe Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 77. Europe Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 78. Europe Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 79. Europe Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 80. Europe Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 81. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 82. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 83. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 84. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 85. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Region (2018-2023) & (USD Million)
Table 86. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value by Region (2024-2029) & (USD Million)
Table 87. South America Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 88. South America Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 89. South America Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 90. South America Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 91. South America Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 92. South America Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 93. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Type (2018-2023) & (USD Million)
Table 94. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Type (2024-2029) & (USD Million)
Table 95. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Application (2018-2023) & (USD Million)
Table 96. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Application (2024-2029) & (USD Million)
Table 97. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Country (2018-2023) & (USD Million)
Table 98. Middle East & Africa Postoperative Nausea and Vomiting Management Consumption Value by Country (2024-2029) & (USD Million)
Table 99. Postoperative Nausea and Vomiting Management Raw Material
Table 100. Key Suppliers of Postoperative Nausea and Vomiting Management Raw Materials
LIST OF FIGURES
Figure 1. Postoperative Nausea and Vomiting Management Picture
Figure 2. Global Postoperative Nausea and Vomiting Management Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type in 2022
Figure 4. Serotonin Antagonists
Figure 5. Steroids
Figure 6. Dopamine Antagonists
Figure 7. Neurokinin NK-1 Receptor Antagonists
Figure 8. Non-pharmacological Treatment
Figure 9. Global Postoperative Nausea and Vomiting Management Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application in 2022
Figure 11. Hospital Pharmacies Picture
Figure 12. Online Pharmacies Picture
Figure 13. Retail Pharmacies and Drug Stores Picture
Figure 14. Global Postoperative Nausea and Vomiting Management Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Postoperative Nausea and Vomiting Management Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Postoperative Nausea and Vomiting Management Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Region in 2022
Figure 19. North America Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Postoperative Nausea and Vomiting Management Revenue Share by Players in 2022
Figure 25. Postoperative Nausea and Vomiting Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Postoperative Nausea and Vomiting Management Market Share in 2022
Figure 27. Global Top 6 Players Postoperative Nausea and Vomiting Management Market Share in 2022
Figure 28. Global Postoperative Nausea and Vomiting Management Consumption Value Share by Type (2018-2023)
Figure 29. Global Postoperative Nausea and Vomiting Management Market Share Forecast by Type (2024-2029)
Figure 30. Global Postoperative Nausea and Vomiting Management Consumption Value Share by Application (2018-2023)
Figure 31. Global Postoperative Nausea and Vomiting Management Market Share Forecast by Application (2024-2029)
Figure 32. North America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 42. France Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value Market Share by Region (2018-2029)
Figure 49. China Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 52. India Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 66. Postoperative Nausea and Vomiting Management Market Drivers
Figure 67. Postoperative Nausea and Vomiting Management Market Restraints
Figure 68. Postoperative Nausea and Vomiting Management Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Postoperative Nausea and Vomiting Management in 2022
Figure 71. Manufacturing Process Analysis of Postoperative Nausea and Vomiting Management
Figure 72. Postoperative Nausea and Vomiting Management Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
Figure 1. Postoperative Nausea and Vomiting Management Picture
Figure 2. Global Postoperative Nausea and Vomiting Management Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type in 2022
Figure 4. Serotonin Antagonists
Figure 5. Steroids
Figure 6. Dopamine Antagonists
Figure 7. Neurokinin NK-1 Receptor Antagonists
Figure 8. Non-pharmacological Treatment
Figure 9. Global Postoperative Nausea and Vomiting Management Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 10. Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application in 2022
Figure 11. Hospital Pharmacies Picture
Figure 12. Online Pharmacies Picture
Figure 13. Retail Pharmacies and Drug Stores Picture
Figure 14. Global Postoperative Nausea and Vomiting Management Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 15. Global Postoperative Nausea and Vomiting Management Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 16. Global Market Postoperative Nausea and Vomiting Management Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 17. Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Region (2018-2029)
Figure 18. Global Postoperative Nausea and Vomiting Management Consumption Value Market Share by Region in 2022
Figure 19. North America Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 20. Europe Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 21. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 22. South America Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 23. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 24. Global Postoperative Nausea and Vomiting Management Revenue Share by Players in 2022
Figure 25. Postoperative Nausea and Vomiting Management Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 26. Global Top 3 Players Postoperative Nausea and Vomiting Management Market Share in 2022
Figure 27. Global Top 6 Players Postoperative Nausea and Vomiting Management Market Share in 2022
Figure 28. Global Postoperative Nausea and Vomiting Management Consumption Value Share by Type (2018-2023)
Figure 29. Global Postoperative Nausea and Vomiting Management Market Share Forecast by Type (2024-2029)
Figure 30. Global Postoperative Nausea and Vomiting Management Consumption Value Share by Application (2018-2023)
Figure 31. Global Postoperative Nausea and Vomiting Management Market Share Forecast by Application (2024-2029)
Figure 32. North America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 33. North America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 34. North America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 35. United States Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 36. Canada Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 37. Mexico Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 38. Europe Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 39. Europe Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 40. Europe Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 41. Germany Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 42. France Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 43. United Kingdom Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 44. Russia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 45. Italy Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 46. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 47. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 48. Asia-Pacific Postoperative Nausea and Vomiting Management Consumption Value Market Share by Region (2018-2029)
Figure 49. China Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 50. Japan Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 51. South Korea Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 52. India Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 53. Southeast Asia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 54. Australia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 55. South America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 56. South America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 57. South America Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 58. Brazil Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 59. Argentina Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 60. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value Market Share by Type (2018-2029)
Figure 61. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value Market Share by Application (2018-2029)
Figure 62. Middle East and Africa Postoperative Nausea and Vomiting Management Consumption Value Market Share by Country (2018-2029)
Figure 63. Turkey Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 64. Saudi Arabia Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 65. UAE Postoperative Nausea and Vomiting Management Consumption Value (2018-2029) & (USD Million)
Figure 66. Postoperative Nausea and Vomiting Management Market Drivers
Figure 67. Postoperative Nausea and Vomiting Management Market Restraints
Figure 68. Postoperative Nausea and Vomiting Management Market Trends
Figure 69. Porters Five Forces Analysis
Figure 70. Manufacturing Cost Structure Analysis of Postoperative Nausea and Vomiting Management in 2022
Figure 71. Manufacturing Process Analysis of Postoperative Nausea and Vomiting Management
Figure 72. Postoperative Nausea and Vomiting Management Industrial Chain
Figure 73. Methodology
Figure 74. Research Process and Data Source
